Kojic Acid in Skincare
Kojic acid is a well-supported brightening ingredient for melasma. Leave-on format, concentration, formula stability, irritation risk, and sun protection matter more than choosing the highest percentage.
- Aliases
- 5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one
- Ingredient category
- Brightening Ingredient
- Most relevant for
- Hyperpigmentation
- Evidence strength
- Well Supported for Improving melasma severity with topical kojic-acid formulations
- Formula matters
- Concentration, leave-on versus rinse-off format, stability, vehicle, contact time, supporting brightening ingredients, irritation burden, and sunscreen use determine results; higher percentage is not automatically better.
- Separate product needed?
- Usually No. Most routines do not need a separate kojic acid product when another pigment treatment is already working well.
BB takeaway
Kojic acid is a credible melasma-focused ingredient, but percentage is not a quality score. Choose a stable, tolerable leave-on formula and consistent sun protection rather than adding another brightening step by default.
Ingredient evidence does not prove the performance of every finished product containing it.
What is kojic acid?
Kojic acid is a small compound produced by certain fungi and microorganisms during fermentation. In skincare, it is used mainly as a brightening ingredient for excess pigmentation.
It works partly by interfering with tyrosinase, an enzyme involved in melanin production. That gives kojic acid a credible role in pigment-focused formulas, but it does not remove the trigger behind the discoloration or guarantee that every dark mark will fade.
Kojic acid is different from derivatives such as kojic dipalmitate. Those materials can have different stability, penetration, and evidence, so research on kojic acid itself should not automatically be transferred to them.
What does kojic acid do for skin?
Kojic acid is best supported for reducing excess pigmentation, particularly melasma.
It may also appear in formulas for post-inflammatory dark marks and uneven tone, but the evidence for those broader uses is less direct than it is for melasma.
Kojic acid is not an exfoliating acid. It does not unclog pores, treat active acne, erase indented scars, correct redness, or permanently prevent pigment from returning.
Light exposure, acne, friction, inflammation, and hormonal influences can continue to stimulate pigment while you use a brightening product.
What the evidence says about kojic acid skincare
Kojic acid is well supported for improving melasma severity with topical formulas.
A 2023 systematic review and meta-analysis evaluated topical melasma treatments across 45 efficacy studies involving 2,359 patients. Kojic acid produced a statistically significant pooled improvement in melasma scores and was among the non-hydroquinone options the authors considered reasonable alternatives depending on tolerance and clinical context.[1]
A separate systematic review of 174 randomized or controlled melasma trials gave kojic acid a Grade A recommendation alongside hydroquinone, triple-combination creams, sunscreens, and azelaic acid.[2]
Individual trials reinforce that conclusion without establishing one ideal concentration. A randomized single-blind study of 80 patients found that 1% kojic acid cream improved melasma over 12 weeks, while some combination regimens produced stronger results.[3]
In a 2025 randomized open-label study of 72 Indian women, a leave-on cream containing 2% kojic acid with vitamin C and a 5% cysteamine cream both produced modest improvement over 16 weeks, with no statistically significant difference between groups.[4] Because the kojic-acid product also contained vitamin C, the result does not isolate kojic acid. The cysteamine cream was washed off after 15 minutes, while the kojic acid–vitamin C cream remained on overnight. Two participants in the kojic-acid group were lost to follow-up.
For your routine, kojic acid is a legitimate melasma-focused brightening ingredient, but it is not automatically the strongest treatment or the right choice for every type of discoloration.
How kojic acid form and formulation affect results
Leave-on format, concentration, stability, vehicle, contact time, supporting ingredients, and irritation risk all affect how a kojic acid product performs.
A leave-on serum or cream gives kojic acid more contact time than a cleanser or soap, so it is usually the more logical format when visible pigment change is the goal.
Higher percentage is not automatically better. The European Union restricts kojic acid used as a skin-lightening ingredient to a maximum of 1% in face and hand products.[5] That is an EU safety restriction, not a universal efficacy target and not a U.S. concentration rule.
Clinical studies have used higher concentrations, including the 2% cream in the 2025 melasma trial.[4] A study concentration should not be treated as proof that a stronger cosmetic is automatically better or more appropriate for home use.
Kojic acid also appears in combination formulas with vitamin C, glycolic acid, niacinamide, alpha arbutin, tranexamic acid, azelaic acid, or retinoids. Improvement from a multi-active formula belongs to the complete product unless the ingredients were tested separately.
Who may benefit from kojic acid skincare?
Kojic acid makes the most sense when melasma or another melanin-driven form of hyperpigmentation is a clear concern and daily sun protection is already in place.
It can be especially reasonable when you want a non-exfoliating pigment treatment and the complete formula is simple enough to use consistently.
You may not need it if another well-tolerated pigment treatment is already working.
If active acne, friction, irritation, or another trigger keeps creating new marks, controlling that trigger can matter more than adding another brightening ingredient.
Kojic acid side effects and irritation risk
The main practical concern is irritation. Kojic acid products can cause stinging, burning, redness, itching, dryness, peeling, or allergic contact dermatitis in some users.
The Scientific Committee on Consumer Safety concluded that kojic acid is safe as a skin-lightening ingredient in cosmetics at concentrations up to 1% under the assessed conditions. It also noted additional concern when kojic acid is used with peeling agents or on a weakened skin barrier because dermal absorption may increase.[6]
The complete routine matters. Exfoliating acids, retinoids, scrubs, peels, fragrance, and multiple pigment actives can make a kojic-acid routine harder to tolerate even when each ingredient looks reasonable on its own.
Stop using a product that causes persistent burning, swelling, blistering, or a worsening rash. Do not apply it to sunburned, broken, freshly peeled, or severely irritated skin.
How to use kojic acid in your skincare routine
Follow the directions on the exact product.
For a leave-on serum or cream, starting less frequently can make it easier to judge tolerability before moving to more regular use.
Introduce one new pigment-active product at a time. Starting kojic acid during the same week as a new retinoid, peel, exfoliating toner, or strong acid makes irritation harder to identify.
Use broad-spectrum sunscreen every morning. For melasma, visible-light protection also matters; tinted sunscreen containing iron oxides can add protection against visible light.[7]
How long does kojic acid take to work?
Think in weeks to months rather than days.
Randomized melasma studies have evaluated kojic-acid formulas over roughly 12 to 16 weeks.[3][4]
Those study durations are not universal promises. Formula, concentration, type and depth of pigmentation, sunscreen use, and skin tolerance all affect the timeline.
More peeling is not a sign that pigment will fade faster. Irritation can make post-inflammatory discoloration harder to control.
What can you use with kojic acid?
Kojic acid can fit into routines with niacinamide, vitamin C, alpha arbutin, tranexamic acid, azelaic acid, and other pigment-focused ingredients when the routine remains comfortable.
Use more caution with glycolic acid, lactic acid, salicylic acid, retinoids, benzoyl peroxide, scrubs, peel pads, and at-home peels. These products are not automatically incompatible, but combining several irritating treatments can worsen post-inflammatory hyperpigmentation.
A gentle cleanser, dependable moisturizer, and daily sunscreen often support a pigment routine more effectively than another brightening layer.
How to choose a kojic acid product
Start with the format and the pigmentation you want to treat.
A leave-on cream or serum is a more logical choice than a rinse-off soap when the goal is meaningful contact time.
Look for clear directions, a realistic application area, concentration information when available, and a formula that does not overload the routine with exfoliating or irritating ingredients.
Do not interpret the EU 1% ceiling as the ideal strength. It is a safety restriction for that market, while clinical studies use different formulas and concentrations.
Be cautious with “100% kojic acid,” pure powders, full-body lightening products, “medical grade,” and claims that a product will permanently erase melasma or dark spots.
Kojic acid alone does not justify Premium pricing. Pay more only when the finished product gives you a meaningful advantage in stability, packaging, tolerability, formula design, or credible finished-product testing.
Do you need a separate kojic acid product?
Usually, no.
A separate kojic acid product can make sense when melasma or persistent hyperpigmentation remains a real gap and your current pigment routine is not already doing the job.
If another treatment is working or your skin is already irritated, adding kojic acid may increase complexity without improving the result.
The BB Perspective
Kojic acid is a legitimate brightening ingredient with solid human evidence for melasma.
The mistake is turning that evidence into a concentration contest. Leave-on format, formula stability, irritation risk, sunscreen use, and the type of pigmentation matter more than chasing the biggest number on the label.
Choose kojic acid when it fills a real pigment-treatment gap. If another evidence-backed product is already working, you do not need a separate kojic acid step just because the ingredient is popular.
Last reviewed: September 2026
Sources
Chang YF, Lee TL, Oyerinde O, et al. Efficacy and safety of topical agents in the treatment of melasma: What’s evidence? A systematic review and meta-analysis. Journal of Cosmetic Dermatology. 2023;22(4):1168-1176. doi:10.1111/jocd.15566. PMID:36566490.
This meta-analysis included 45 efficacy studies with 2,359 patients and 55 adverse-effect studies with 4,539 patients. Kojic acid produced a statistically significant pooled improvement in melasma severity. The included formulas and study designs varied, so the result supports the ingredient’s melasma role without predicting the performance of every retail product. Six kojic-acid studies contributed to the pooled analysis, which had high overall heterogeneity (I²=83%). The publication lists conflicts of interest as “Not applicable” and does not identify a funding source. Return to citation.
Sarkar R, Handog EB, Das A, et al. Topical and Systemic Therapies in Melasma: A Systematic Review. Indian Dermatology Online Journal. 2023;14(6):769-781. doi:10.4103/idoj.idoj_490_22. PMID:38099013. PMCID:PMC10718129.
This systematic review identified 174 randomized or controlled trials and gave kojic acid a Grade A recommendation for melasma. The review covers multiple formulations and comparisons, so the grade supports the treatment category rather than one ideal product or concentration. The authors reported no conflicts of interest. The authors reported no financial support or sponsorship. Return to citation.
Deo KS, Dash KN, Sharma YK, Virmani NC, Oberai C. Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety. Indian Journal of Dermatology. 2013;58(4):281-285. doi:10.4103/0019-5154.113940. PMID:23918998. PMCID:PMC3726874.
This randomized single-blind study enrolled 80 patients and compared 1% kojic acid alone with several combination regimens over 12 weeks. Kojic acid alone improved melasma, while some combinations produced stronger responses. The result supports activity at 1% without establishing 1% as the only useful concentration. The investigators reported that the trial received no financial support from any agency. Return to citation.
Patil R, Dhoot D, Balasubramanian A, Patil S, Barkate H. Comparison of the Effectiveness and Safety of 5% Cysteamine and 2% Kojic Acid Creams in the Treatment of Melasma in Indian Adult Females. Cureus. 2025;17(3):e81330. doi:10.7759/cureus.81330. PMID:40296942. PMCID:PMC12036495.
This randomized open-label study included 72 adult women with facial melasma. It compared 5% cysteamine cream with a leave-on cream containing 2% kojic acid plus vitamin C. Both groups improved modestly over 16 weeks, with no statistically significant difference between them. Four authors were Glenmark Pharmaceuticals employees; the fifth worked at the trial site, Mascot Spincontrol. Glenmark supplied study materials and assisted with data collation, analysis, and manuscript preparation. The authors stated that Glenmark did not influence the article’s design or content. Two kojic-acid participants were lost to follow-up, and the treatment contact times differed. The kojic-acid comparator also contained vitamin C, so the study cannot isolate kojic acid or establish an ideal 2% concentration. Return to citation.
European Commission. Commission Regulation (EU) 2024/996 of 3 April 2024.
The regulation restricts kojic acid used as a skin-lightening ingredient to face and hand products at a maximum concentration of 1% in the European Union. This is a market-specific safety restriction, not an efficacy target or a U.S. concentration rule. Return to citation.
Scientific Committee on Consumer Safety. Scientific Opinion on Kojic Acid, SCCS/1637/21. Final opinion adopted March 2022; corrigendum June 2022.
The SCCS concluded that kojic acid is safe as a skin-lightening ingredient in cosmetics up to 1% under the assessed conditions. It noted additional concern when kojic acid is used with peeling agents or on a weakened skin barrier because absorption may increase. Kojic acid derivatives were not included in the assessment. Return to citation.
American Academy of Dermatology. Melasma: Self-care.
This dermatologist-reviewed guidance emphasizes broad-spectrum sunscreen and notes that visible light can worsen melasma. It recommends tinted sunscreen containing iron oxides to help protect against visible light. This source supports photoprotection guidance rather than kojic acid efficacy. Return to citation.
Products featuring Kojic Acid
These evaluated products list Kojic Acid among the Key Ingredients that meaningfully shape the formula. Inclusion here reflects ingredient relevance, not an endorsement or rating.
